WebApr 1, 2024 · Roche announced that it has launched the Elecsys EBV panel in countries accepting the CE Mark. Roche will file for approval with the U.S. Food and Drug Administration (FDA) in the future, according to a news release from the company. The Elecsys EBV panel consists of three immunoassays: Elecsys EBV IgM, Elecsys EBV VCA … WebDec 16, 2024 · The Elecsys ® SARS-CoV-2 Antigen test is a highly accurate laboratory immunoassay for the in vitro qualitative detection of the nucleocapsid antigen of SARS-CoV-2. In clinical studies, the Elecsys SARS-CoV-2 Antigen test showed a 94.5% sensitivity across 200 PCR confirmed symptomatic individuals and a 99.9% specificity across 2747 PCR …
Roche to launch laboratory SARS-CoV-2 antigen test to support ... - Nasdaq
WebDec 11, 2024 · Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients Published Dec 11, 2024 1:00AM EST The Elecsys® SARS-CoV-2 Antigen test is an... WebJul 18, 2024 · Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus. Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status. cleaner for oven shelves
Elecsys® HIV Duo - Diagnostics
WebRoche Group Diagnostics pipeline. PDF. Roche Group Pharmaceuticals pipeline. PDF. Genentech Pipeline. Our R&D activities are focused on applying excellent science to … WebMar 31, 2024 · Roche launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve EBV infection staging F. Hoffmann-La Roche Ltd 31 March 2024, 1:00 am · 7-min read The Elecsys EBV panel... WebApr 7, 2024 · Basel, 07 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys Anti-p53 immunoassay for the in vitro quantitative … downtown crossing station boston